haritaki terminalia chebula
Selected indexed studies
- Hypolipidemic activity of haritaki (terminalia chebula) in atherogenic diet induced hyperlipidemic rats. (J Adv Pharm Technol Res, 2010) [PMID:22247850]
- A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. (Heliyon, 2022) [PMID:36051270]
- A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz]. (Ayu, 2012) [PMID:23723658]
_Worker-drafted node — pending editorial review._
Connections
haritaki terminalia chebula helps
Sources
- Hypolipidemic activity of haritaki (terminalia chebula) in atherogenic diet induced hyperlipidemic rats. (2010) pubmed
- A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. (2022) pubmed
- A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz]. (2012) pubmed
- Bangladeshi medicinal plant dataset. (2023) pubmed
- From Ancient Fruit to Functional Innovation: Liposomal Delivery of Haritaki (Terminalia chebula) Fruit Extract via Chocolate Matrix. (2026) pubmed
- A comprehensive metabolome profiling of Terminalia chebula, Terminalia bellerica, and Phyllanthus emblica to explore the medicinal potential of Triphala. (2024) pubmed
- 1,3,6-Trigalloylglucose: A Novel Potent Anti-Helicobacter pylori Adhesion Agent Derived from Aqueous Extracts of Terminalia chebula Retz. (2024) pubmed
- A standardized combination of Boswellia serrata and Terminalia chebula extracts to improve cognition in adults with subjective memory complaints: a randomized controlled proof-of-concept study. (2025) pubmed
- Haritaki (Chebulic myrobalan) and its varieties. (2013) pubmed
- Triphala's characteristics and potential therapeutic uses in modern health. (2025) pubmed